Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
93.2M
-
Shares change
-
-10.1M
-
Total reported value, excl. options
-
$8.85B
-
Value change
-
-$922M
-
Put/Call ratio
-
0.68
-
Number of buys
-
144
-
Number of sells
-
-127
-
Price
-
$94.98
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q2 2018
335 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q2 2018.
DEXCOM INC - Common Stock (DXCM) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.2M shares
of 392M outstanding shares and own 23.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.13M shares), FMR LLC (7.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.58M shares), BAILLIE GIFFORD & CO (5.2M shares), Capital World Investors (5.18M shares), MORGAN STANLEY (5.03M shares), JANUS HENDERSON GROUP PLC (4.44M shares), BlackRock Inc. (4.12M shares), WELLINGTON MANAGEMENT GROUP LLP (4.05M shares), and BROWN ADVISORY INC (3.18M shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.